Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥29,965 | ¥17,464 | ¥16,555 | ¥18,212 |
| - Cash | ¥2,207 | ¥2,727 | ¥3,607 | ¥4,381 |
| + Debt | ¥11,885 | ¥8,719 | ¥4,958 | ¥3,447 |
| Enterprise Value | ¥39,643 | ¥23,456 | ¥17,906 | ¥17,278 |
| Revenue | ¥50,643 | ¥46,895 | ¥45,101 | ¥43,464 |
| % Growth | 8% | 4% | 3.8% | – |
| Gross Profit | ¥8,638 | ¥9,839 | ¥10,331 | ¥11,459 |
| % Margin | 17.1% | 21% | 22.9% | 26.4% |
| EBITDA | ¥7,413 | ¥7,920 | ¥8,958 | ¥9,881 |
| % Margin | 14.6% | 16.9% | 19.9% | 22.7% |
| Net Income | ¥1,908 | ¥3,295 | ¥3,600 | ¥4,668 |
| % Margin | 3.8% | 7% | 8% | 10.7% |
| EPS Diluted | 62.72 | 105 | 113.71 | 152.45 |
| % Growth | -40.3% | -7.7% | -25.4% | – |
| Operating Cash Flow | ¥5,897 | ¥5,182 | ¥4,155 | ¥4,370 |
| Capital Expenditures | -¥6,854 | -¥6,276 | -¥5,556 | -¥4,733 |
| Free Cash Flow | -¥957 | -¥1,094 | -¥1,401 | -¥363 |